ethoxzolamide (ethamide) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Ethoxzolamide is a carbonic anhydrase I inhibitor. It is used in the treatment of glaucoma and duodenal ulcers, and as a diuretic. Ethoxzolamide was marketed under trade name Cadrase, but is now discontinued.   NCATS

Chemistry

  • SMILES: CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O
  • InChIKey: OUZWUKMCLIBBOG-UHFFFAOYSA-N
  • Mol. Mass: 258.317
  • ALogP: 3.89
  • ChEMBL Molecules:
    imipraminoxide  
    ethoxzolamide  
More Chemistry

Pharmacology

Alternative names

6-ethoxy-1,3-benzothiazole-2-sulfonamide | cardrase | ethamide | ethoxazolamide | ethoxyzolamide | ethoxzolamide | etoxzolamide

Organizations (2)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (2)


 

Duodenal Ulcer

Glaucoma

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue